Bliss GVS Pharma Limited
360 ONE AIF increased its stake in Bliss GVS Pharma Limited from 1.16% to 1.99% by acquiring 8,84,910 shares. This transaction was executed through a rights issue.
A pharmaceutical manufacturer engaged in producing and marketing a diverse range of formulations including suppositories, pessaries, capsules, tablets, and syrups. The company operates across manufacturing, marketing, trading, and export functions, serving both domestic and international markets. Established in 1984, it has developed specialized expertise in multiple dosage forms and maintains an integrated operation across the pharmaceutical value chain to address varied healthcare requirements.
360 ONE AIF is the alternative investments arm of 360 ONE Asset Management, formerly IIFL Asset Management, part of the 360 ONE group. It manages alternative investment funds spanning listed equity, private equity and private credit strategies for sophisticated and institutional investors, led by chief investment officer Anup Maheshwari.